Isfahan University of Medical Sciences Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT02226913
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Ali Amoushahi

Active Ingredients

Drugs in Phase 3 Trials (4)

epinephrine (levophed) (1 trial)

lidocaine (xylocaine) (2 trials)

sodium bicarbonate (2 trials)

water (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pulpitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4